Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma
Source abstract
Abstract
The unique tumour microenvironment (TM) of pancreatic ductal adenocarcinoma (PDA) including highly desmoplastic ECM and low tumour perfusion supports a considerable barrier for effective delivery of nanomedicines. Effectively modulating PDA microenvironment to enhance tumour drug delivery represents a pinpoint in the field of PDA treatment. In this study, it was the first time that biomimetic nanoparticles, which were designed in the form of erythrocyte membrane-camouflaged PLGA nanoparticles (MNP), were utilized for PDA microenvironment modulation. Cyclopamine (CYC), an inhibitor of Hedgehog pathway that contributed a lot to desmoplastic ECM of PDA, was selected as the model drug and successfully encapsulated into MNP. Advantages of CYC-loaded MNP (CMNP) included favourable biocompatibility, long circulation time, and powerful TM modulation effect. CMNP could effectively deliver CYC to the tumour site, disrupt tumour ECM, increase functional vessels, and improve tumour perfusion significantly. The combination treatment with CMNP and PTX-loaded MNP (PMNP) successfully improved PTX delivery to tumour, resulting in remarkable tumour growth inhibition in vivo. Therefore, biomimetic nanoparticles provide a new strategy for modulating PDA TM and will have great potential to improve the therapeutic effects of nanomedicines for PDA patients.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hedgehog Signaling Pathway Studies · Pancreatic and Hepatic Oncology Research · Phagocytosis and Immune Regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Funding
National Natural Science Foundation of China · HUST
References (23)
Show source-provided references
1. 10.1158/1078-0432.CCR-11-311410.1158/1078-0432.CCR-11-3114 ↗
2. 10.1016/j.ccr.2012.02.02210.1016/j.ccr.2012.02.022 ↗
3. 10.1038/nature0727510.1038/nature07275 ↗
4. 10.1021/acsami.7b0945810.1021/acsami.7b09458 ↗
5. 10.1021/jm800850810.1021/jm8008508 ↗
6. 10.1021/nn404501g10.1021/nn404501g ↗
7. 10.1021/nn900002m10.1021/nn900002m ↗
8. 10.1039/C5NR03730A10.1039/C5NR03730A ↗
9. 10.1002/adhm.20120013810.1002/adhm.201200138 ↗
10. 10.7150/thno.1447110.7150/thno.14471 ↗
11. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
12. 10.1073/pnas.141242011110.1073/pnas.1412420111 ↗
13. 10.1016/j.nano.2016.07.01710.1016/j.nano.2016.07.017 ↗
14. 10.1016/j.biomaterials.2016.06.04810.1016/j.biomaterials.2016.06.048 ↗
15. 10.1158/1078-0432.CCR-08-029110.1158/1078-0432.CCR-08-0291 ↗
16. 10.1016/j.ccr.2012.01.00710.1016/j.ccr.2012.01.007 ↗
17. 10.1021/acs.nanolett.6b0082010.1021/acs.nanolett.6b00820 ↗
18. 10.1158/0008-5472.CAN-16-164610.1158/0008-5472.CAN-16-1646 ↗
19. 10.1126/science.117136210.1126/science.1171362 ↗
20. 10.1038/nmat379210.1038/nmat3792 ↗
21. Yang S, Gao H. Nanoparticles for modulating tumour microenvironment to improve drug delivery and tumour therapy. Pharmacol Res. 2017;6618:30163–30169.
22. 10.1039/b805754k10.1039/b805754k ↗
23. 10.1039/C3NR06371B10.1039/C3NR06371B ↗